Asthma Linked to Memory Difficulties in Children
By Elana Gotkine HealthDay Reporter
TUESDAY, Nov. 12, 2024 -- Asthma is associated with memory difficulties in children, according to a study published online Nov. 11 in JAMA Network Open.
Nicholas J. Christopher-Hayes, from the University of California Davis, and colleagues examined whether childhood asthma is associated with lower memory abilities in children using observational data from the Adolescent Brain Cognitive Development Study, which enrolled approximately 11,800 children aged 9 to 10 years at baseline.
The longitudinal analysis included 474 children. The researchers found that relative to the comparison group, children with an earlier onset of asthma exhibited lower rates of longitudinal memory improvements (β = −0.17). The cross-sectional analysis included 2,062 children (1,031 with asthma and 1,031 without asthma). Lower scores on episodic memory (β = −0.09), processing speed (β = −0.13), and inhibition and attention (β = −0.11) were seen for children with asthma.
"The current study provides novel evidence that children with asthma exhibit altered memory functioning during development, in addition to consequences extending to other cognitive domains," the authors write. "These results accentuate the need to examine this population more closely to understand the full extent to which asthma influences neurodevelopment."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
Risk for Dementia, Ischemic Stroke, Mortality Lower With GLP-1 Receptor Agonists in T2D, Obesity
TUESDAY, July 22, 2025 -- For adults with type 2 diabetes and obesity, glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a lower risk for dementia, stroke...
Dementia Risk Does Not Differ With GLP-1 RAs, DPP4is for Seniors With T2DM
MONDAY, July 21, 2025 -- For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using glucagon-like peptide 1...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.